We have not found any cost information for this lawyer
About Mark
Practice Areas
2
Practice Areas
Fees and Rates
Looking for an attorney? Avvo can help.
Search our directory
Quickly connect with top attorneys through our legal directory to get help with your legal issue.
Avvo's live chat agents can help coordinate a consultation with a local attorney.
Chat with a live agent who can match you with the right attorney for your legal needs.
Chat withLicenses
Licensed in New York for 40 years
State: New York
Acquired: 1986
No misconduct found
Licensed in Connecticut for 40 years
State: Connecticut
Acquired: 1985
No misconduct found
Location
Ropes and Gray LLP
800 Boylston St, Prudential Tower, Boston, MA, 02199-3600
Ropes and Gray LLP
800 Boylston St, Boston, MA, 02199-8001
Ad
Transform legal challenges into solutions.
Connect now to review your situation.
Mark Barnes's Reviews
Avvo Review Score
Not Yet Reviewed
Mark Barnes's Lawyer Endorsements
No Endorsement Data Available Yet
This attorney hasn't received any attorney endorsements recently on Avvo.
No Endorsement Data Available Yet
This attorney hasn't created any attorney endorsements recently on Avvo.
Experience
Honors
2007
The Best Lawyers in America,
2006
America's Leading Lawyers for Business,
2006
New York Super Lawyers,
Education
1991
Columbia University School of Law
LL.M - Master of Laws
1984
Yale Law School
JD - Juris Doctor
1981
Bennington College
BA - Bachelor of Arts
Publications
2007
Medical Research Law & Policy Report
Health care team looks back — and ahead — at developments in human subjects research
2006
Medical Research Law & Policy (BNA)
Barnes, Hermes, Brooks examine ownership of biological materials
2006
Medical Research Law & Policy Report,
Ropes & Gray team analyzes FDA draft guidance on emergency research
2005
Journal of Health and Hospital Law
Barnes, Korn analyze Medicare Reimbursement for Clinical Trial Services
2005
New Perspectives
Barnes, Claiborne, Hermes caution grant administrators to keep eye on FCA
N/A
Medical Research Law & Policy Report
Firm trio details issues confronting clinical trials in 2006